Cas No. |
Product name |
1163-36-6 |
Clemizole hydrochloride |
more... |
Clemizole Hcl is a H1 histamine receptor antagonist. Recently, researchers have identified that clemizole hydrochloride can inhibit NS4B's RNA binding and hepatitis C virus (... |
1423715-09-6 |
SP2509 |
more... |
SP2509 is a novel histone demethylase LSD1 (KDM1A) antagonist with IC50 of 13 nM; no inhibition on MAO-A and MAO-B. |
1373423-53-0 |
GSK J4 |
more... |
GSK J4 is a cell permeable prodrug rapidly hydrolyzed by macrophage esterases to GSK-J1, a potent selective jumonji H3K27 demethylase inhibitor; attenuates lipopolysaccharide... |
1616391-65-1 |
EPZ015666 |
more... |
EPZ015666 is a potent, selective and orally bioavailable PRMT5 inhibitor with Ki of 5 nM, >20,000-fold selectivity over other PMTs. |
1197196-48-7 |
UNC0224 |
more... |
UNC0224 is a potent and selective G9a inhibitor with IC50 of 15 nM in the G9a Thioglo assay. |
1431368-48-7(free base) |
GSK-LSD1 2HCl |
more... |
GSK-LSD1 2HCl is an irreversible, and selective LSD1 inhibitor with IC50 of 16 nM, > 1000 fold selective over other closely related FAD utilizing enzymes (i.e. LSD2, MAO-A... |
1431326-61-2 |
ORY-1001 |
more... |
LSD1-IN-1 is a potent LSD1 inhibitor extracted from patent WO2013057322A1. |
1431326-61-2 |
ORY-1001 (RG-6016) |
more... |
ORY-1001 (RG-6016) is an orally active and selective lysine-specific demethylase LSD1/KDM1A inhibitor with IC50 of <20 nM, with high selectivity against related FAD depend... |
1320288-17-2 |
UNC0646 |
more... |
UNC0646 G9a selective inhibitor, IC50 of 6 nM. |